Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71
Loop Capital analyst Christopher Kapsch downgrades Corteva (NYSE:CTVA) from Buy to Hold and raises the price target from $70 to $71.
Raymond James Downgrades NexImmune to Market Perform
Raymond James analyst Steven Seedhouse downgrades NexImmune (NASDAQ:NEXI) from Outperform to Market Perform.
Raymond James Downgrades C.H. Robinson Worldwide to Underperform
Raymond James analyst Felix Boeschen downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Market Perform to Underperform.
Guggenheim Downgrades Neoleukin Therapeutics to Neutral
Guggenheim analyst Michael Schmidt downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.
National Bank Of Canada Downgrades Taiga Motors to Sector Perform, Lowers Price Target to C$5.5
National Bank Of Canada analyst Cameron Doerksen downgrades Taiga Motors (TSX:TAIG) from Outperform to Sector Perform and lowers the price target from C$8 to C$5.5.
Jefferies Downgrades Madison Square Garden to Hold, Lowers Price Target to $49
Jefferies analyst David Katz downgrades Madison Square Garden (NYSE:MSGE) from Buy to Hold and lowers the price target from $100 to $49.
Mizuho Downgrades LyondellBasell Industries to Neutral, Announces $88 Price Target
Mizuho analyst Christopher Parkinson downgrades LyondellBasell Industries (NYSE:LYB) from Buy to Neutral and announces $88 price target.
SVB Leerink Downgrades Calithera Biosciences to Market Perform, Lowers Price Target to $2
SVB Leerink analyst Jonathan Chang downgrades Calithera Biosciences (NASDAQ:CALA) from Outperform to Market Perform and lowers the price target from $18 to $2.
SVB Leerink Downgrades Satsuma Pharmaceuticals to Market Perform, Lowers Price Target to $1
SVB Leerink analyst Marc Goodman downgrades Satsuma Pharmaceuticals (NASDAQ:STSA) from Outperform to Market Perform and lowers the price target from $15 to $1.
Piper Sandler Downgrades Thoughtworks Holding to Neutral, Lowers Price Target to $9.5
Piper Sandler analyst Arvind Ramnani downgrades Thoughtworks Holding (NASDAQ:TWKS) from Overweight to Neutral and lowers the price target from $14 to $9.5.